Phase 1, First-In-Human Study Of Medi2228, A Bcma-Targeted Adc In Patients With Relapsed/Refractory Multiple Myeloma
Shaji K. Kumar,Magdalini Migkou,Manisha Bhutani,Andrew Spencer,Sikander Ailawadhi,Anna Kalff,Farzana Walcott,Nabendu Pore, Diana Gibson,Fujun Wang,Lily Cheng, Ioannis Kagiampakis,Marna Williams,Krista Kinneer,Yu Jiang,Jeffrey Zonder,Jeremy Larsen,Shreerang Sirdesai,Andrew J. Yee,Meletios A Dimopoulos BLOOD(2020)
AI 理解论文
溯源树
样例